Applied Therapeutics, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Perfetti Riccardo (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.44	2028-12-16	Common Stock (213424)		Direct
Employee Stock Option (right to buy)	$4.70	2029-03-17	Common Stock (133811)		Direct

Footnotes

F1: Thirty-three percent (33%) of the shares subject to the option vested on August 27, 2018, and one twenty-fourth (1/24th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F2: Thirty-three percent (33%) of the shares subject to the option vested on March 18, 2019, and one twenty-fourth (1/24th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.